APA

Shah B., Godse K., Mahajan S., Grandhi S., Shendkar S., Sharma A., Teli C., Pathak R. & Parsad D. (20200518). Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus Tacrolimus 0.1% ointment versus Tacrolimus 0.1% ointment in the treatment of stable vitiligo. : Dermatologic therapy.

Chicago

Shah Bela, Godse Kiran, Mahajan Satyaprakash, Grandhi Sudhakarrao, Shendkar Sonal, Sharma Akhilesh, Teli Chirag, Pathak Rahul and Parsad Davinder. 20200518. Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus Tacrolimus 0.1% ointment versus Tacrolimus 0.1% ointment in the treatment of stable vitiligo. : Dermatologic therapy.

Harvard

Shah B., Godse K., Mahajan S., Grandhi S., Shendkar S., Sharma A., Teli C., Pathak R. and Parsad D. (20200518). Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus Tacrolimus 0.1% ointment versus Tacrolimus 0.1% ointment in the treatment of stable vitiligo. : Dermatologic therapy.

MLA

Shah Bela, Godse Kiran, Mahajan Satyaprakash, Grandhi Sudhakarrao, Shendkar Sonal, Sharma Akhilesh, Teli Chirag, Pathak Rahul and Parsad Davinder. Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus Tacrolimus 0.1% ointment versus Tacrolimus 0.1% ointment in the treatment of stable vitiligo. : Dermatologic therapy. 20200518.